logo

DVA

DaVita·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About DVA

Davita Inc.

A comprehensive kidney care provider that provides dialysis services to patients with end stage renal disease

Healthcare Providers and Services
--
11/03/1995
New York Stock Exchange
76,000
12-31
Common stock
2000 16th Street, Denver, CO 80202
--
DaVita Inc., was incorporated in Delaware in 1994. DaVita is a leading healthcare provider dedicated to transforming the way healthcare is delivered and improving the quality of life for patients around the world. The company provides care to patients at every stage and environment of their kidney health journey — from early diagnosis and prevention to supporting the transplant process.

Earnings Call

Company Financials

EPS

DVA has released its 2025 Q3 earnings. EPS was reported at 2.51, versus the expected 3.17, missing expectations. The chart below visualizes how DVA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

DVA has released its 2025 Q3 earnings report, with revenue of 3.42B, reflecting a YoY change of 4.80%, and net profit of 240.25M, showing a YoY change of -18.77%. The Sankey diagram below clearly presents DVA's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime